- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03293836
Venous Ulcer: Endovenous Radiofrequency Treatment Trial (VUERT)
September 25, 2017 updated by: Juliana Puggina
Venous Ulcer: Endovenous Radiofrequency Treatment of Insufficient Perforating and Saphenous Veins Versus Multilayer Compression Bandaging - Randomized Controlled Clinical Trial
The aim of this study is to analyze the effect of intravenous therapy with radiofrequency for superficial and perforating venous insufficiency versus compression therapy with multilayer banding in patients with active venous ulcer.
This is a controlled, randomized prospective clinical trial.
People with venous ulcers and primary venous insufficiency in superficial and perforating venous system will be studied.
Participants will be divided into two experimental groups: compression therapy alone, and compression therapy associated with superficial and perforating venous system ablation.
Clinical aspects, improvement in patients' quality of life and interventions cost-effectiveness will be analyzed.
Patients will be followed for 12 months after ulcer healing.
Study Overview
Status
Unknown
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
84
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Juliana Puggina, MD
- Phone Number: +5511988604601
- Email: juliana.puggina@usp.br
Study Contact Backup
- Name: Igor R Sincos, PhD
- Phone Number: +5511984477382
- Email: igorsincos@usp.br
Study Locations
-
-
São Paulo
-
Sao Paulo, São Paulo, Brazil, 05403-010
- Recruiting
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (University of São Paulo)
-
Contact:
- Juliana Puggina, MD
- Phone Number: +5511988604601
- Email: juliana.puggina@usp.br
-
Contact:
- Debora Nolli
- Phone Number: +5511999707101
- Email: vuert.trial@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age between 18 and 80 years old
- venous ulcer appeared at least 4 weeks, bellow knee
- ankle-brachial index more than 0.9
- saphenous veins insufficiency plus perforating veins reflux
- saphenous vein diameter between 5 mm and 12 mm
- absence of saphenous veins thrombophlebitis
- absence of personal history of venous deep thrombosis
- absence of ultrasound evidence of actual or previous venous deep thrombosis
- absence of severe ankle anquilosis
Exclusion Criteria:
- Unable to provide informed consent
- Unable to receive surgical intervention due to severe clinical condition
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Radiofrequency treatment
Radiofrequency ablation of insufficient saphenous and perforating veins plus multilayer compressive bandage treatment
|
Radiofrequency ablation of insufficient saphenous and perforating veins using Closure Fast and Closure Stylet catheters (medtronic)
Individual receive multilayer compressive bandage once a week
|
Active Comparator: Multilayer Compressive Bandage only
Receive only compressive treatment
|
Individual receive multilayer compressive bandage once a week
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ulcer Healing - 12 w
Time Frame: 12 weeks
|
Ulcers was already healed after 12 weeks
|
12 weeks
|
Ulcer Healing - 24 w
Time Frame: 24 weeks
|
Ulcers was already healed after 24 weeks
|
24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ulcer Recurrence
Time Frame: 1 year
|
Ulcer recurrence rate after 1 year of follow up
|
1 year
|
Quality of life SF-36
Time Frame: at the begginning and up to 1 week after ulcer had healed
|
Increasing in individual's quality of life using SF 36
|
at the begginning and up to 1 week after ulcer had healed
|
Quality of life EQ- 5D
Time Frame: at the begginning and up to 1 week after ulcer had healed
|
Increasing in individual's quality of life using EQ-5D
|
at the begginning and up to 1 week after ulcer had healed
|
Quality of life VLU-Qol
Time Frame: at the begginning and up to 1 week after ulcer had healed
|
Increasing in individual's quality of life using VLU-Qol
|
at the begginning and up to 1 week after ulcer had healed
|
Quality of life CCVLUQ
Time Frame: at the begginning and up to 1 week after ulcer had healed
|
Increasing in individual's quality of life using VLU-Qol
|
at the begginning and up to 1 week after ulcer had healed
|
Health Economic Assessment
Time Frame: 1 year
|
A cost-effectiveness analysis will be performed using the collected data of resources used in participants care along the study.
Cost-utility (QALY) will be calculated using EQ-5d questionarie data
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Igor R Sincos, PhD, University of Sao Paulo
- Principal Investigator: Juliana Puggina, MD, University of Sao Paulo
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2015
Primary Completion (Anticipated)
October 31, 2017
Study Completion (Anticipated)
August 31, 2018
Study Registration Dates
First Submitted
March 20, 2017
First Submitted That Met QC Criteria
September 25, 2017
First Posted (Actual)
September 26, 2017
Study Record Updates
Last Update Posted (Actual)
September 26, 2017
Last Update Submitted That Met QC Criteria
September 25, 2017
Last Verified
September 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Vuert trial
- UTN (Other Identifier: U1111-1194-4910)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Varicose Ulcer
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedLeg Ulcers | Varicose UlcersNetherlands
-
Medical University of South CarolinaCompletedVenous Ulcers | Leg Ulcers | Varicose UlcersUnited States
-
TheraclionCompletedVaricose Ulcer | Veins Diseases | Vein, VaricoseAustria
-
Groupe Hospitalier Paris Saint JosephActive, not recruiting
-
Andalusian Network for Design and Translation of...Recruiting
-
Oulu University HospitalHelsinki University Central HospitalRecruiting
-
Oulu University HospitalCompleted
-
Nantes University HospitalCompleted
-
University of Turin, ItalyRecruiting
-
Colchester Hospital University NHS Foundation TrustCompleted
Clinical Trials on Radiofrequency ablation
-
Assistance Publique - Hôpitaux de ParisTerminatedHepatocellular CancerFrance
-
Xijing HospitalUnknown
-
Oxford University Hospitals NHS TrustRoyal Bournemouth and Christchurch Hospitals NHS Foundation TrustCompleted
-
Allevio Pain Management ClinicRecruitingShoulder Pain Chronic | Faceto-genic Neck Pain | Faceto-genic HeadacheCanada
-
Southwest Hospital, ChinaCompleted
-
Mansoura UniversityUnknownChronic Knee OsteoarthritisEgypt
-
University of CalgaryRecruitingOsteoarthritis, KneeCanada
-
Assistance Publique - Hôpitaux de ParisCompletedHepatocellular CarcinomasFrance
-
Aalborg University HospitalOdense University Hospital; St. Antonius HospitalTerminatedParoxysmal Atrial Fibrillation.Netherlands, Denmark
-
Ziekenhuis Oost-LimburgBelgium Health Care Knowledge Centre; Klinische Epidemiologie en Medical Technology...RecruitingKnee Osteoarthritis | Chronic Knee Pain | Persistent Postsurgical PainBelgium, Netherlands